Thermo Fisher Scientific, Pfizer Partner to Bring NGS-Based Cancer Tests to Underserved Markets
The collaboration will expand NGS-based tests for lung and breast cancers in more than 30 countries, where advanced genomic testing has been limited.
ACMG: Rare Disease Patients in Poor Countries See Benefit from Clinical Whole-Genome Sequencing
Patients in Illumina's global iHope philanthropic clinical WGS program saw changes in their management regardless of whether they lived in wealthy or poor countries.
Germline Tests Lack Utility for Black South African Prostate Cancer Patients, JNCCN Study Finds
Due to homogenous data informing germline genetic test development, marketed panels don't provide useful prostate cancer risk assessment to patients of sub-Saharan African ancestry, a study showed.
In Brief This Week: FIND, Alverno Laboratories, F-star Therapeutics, Lantern Pharma
News items for the week of March 6, 2023.
Kenyan University Opens Clinical Trial Site for Roche's Investigational KRAS G12C Inhibitor
The university hopes to increase African cancer patients' access to precision therapies through global clinical trials.